{"altmetric_id":2790148,"counts":{"readers":{"mendeley":14,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["202969119794991"],"posts_count":1},"total":{"posts_count":3},"twitter":{"unique_users_count":2,"unique_users":["Flavio58","CancerCureNow"],"posts_count":2}},"selected_quotes":["Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression"],"citation":{"altmetric_jid":"4f6fa6113cf058f610006efa","authors":["Scott M Knowles","Richard Tavare","Kirstin A. Zettlitz","Matthew M Rochefort","Felix Salazar","Ziyue Karen Jiang","Robert E Reiter","Anna M Wu","Knowles SM","Tavare R","Zettlitz KA","Rochefort MM","Salazar F","Jiang ZK","Reiter RE","Wu AM"],"doi":"10.1158\/1078-0432.ccr-14-1452","endpage":"6378","first_seen_on":"2014-10-18T12:44:16+00:00","funders":["nci","nigms"],"issns":["1557-3265","1078-0432"],"issue":"24","journal":"Clinical Cancer Research","last_mentioned_on":1420102149,"links":["http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/17\/1078-0432.CCR-14-1452.abstract?papetoc=","http:\/\/clincancerres.aacrjournals.org\/content\/20\/24\/6367.short?rss=1","http:\/\/clincancerres.aacrjournals.org\/cgi\/content\/short\/20\/24\/6367?rss=1"],"pdf_url":"http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/17\/1078-0432.CCR-14-1452.full.pdf","pmid":"25326233","pubdate":"2014-10-16T23:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"6367","title":"Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and Response to Therapy in Mouse Xenograft Models of Prostate Cancer","type":"article","volume":"20","mendeley_url":"http:\/\/www.mendeley.com\/research\/applications-immunopet-using124iantipsca-a11-minibody-imaging-disease-progression-response-therapy-m"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4691823,"mean":5.4318361211662,"rank":2412021,"this_scored_higher_than_pct":35,"this_scored_higher_than":1665569,"rank_type":"exact","sample_size":4691823,"percentile":35},"similar_age_3m":{"total_number_of_other_articles":124427,"mean":8.6598282513302,"rank":64186,"this_scored_higher_than_pct":37,"this_scored_higher_than":46174,"rank_type":"exact","sample_size":124427,"percentile":37},"this_journal":{"total_number_of_other_articles":4075,"mean":3.7855100638193,"rank":2470,"this_scored_higher_than_pct":29,"this_scored_higher_than":1210,"rank_type":"exact","sample_size":4075,"percentile":29},"similar_age_this_journal_3m":{"total_number_of_other_articles":80,"mean":9.8942784810127,"rank":72,"this_scored_higher_than_pct":5,"this_scored_higher_than":4,"rank_type":"exact","sample_size":80,"percentile":5}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":2,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":5,"Student  > Postgraduate":1,"Student  > Master":2,"Student  > Bachelor":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":6,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1,"Mathematics":1}}},"geo":{"twitter":{"IT":1},"mendeley":{"US":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/Flavio58\/status\/550574436030906368","license":"datasift","citation_ids":[2790148],"posted_on":"2015-01-01T08:49:09+00:00","author":{"name":"Flavio Bernardotti","url":"https:\/\/www.facebook.com\/Flavio58","image":"https:\/\/pbs.twimg.com\/profile_images\/812732443987951616\/aYpgetZQ_normal.jpg","description":"On  the networks since 1985. Computer security, hacking, cracking, computer vision, AI, military spy systems (tempest), electronic. Lunatic insane.","id_on_source":"Flavio58","tweeter_id":"17228282","geo":{"lt":45,"ln":8,"country":"IT"},"followers":2000},"tweet_id":"550574436030906368"},{"url":"https:\/\/twitter.com\/CancerCureNow\/status\/523454289876766720","license":"datasift","citation_ids":[2790148],"posted_on":"2014-10-18T12:43:22+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8381},"tweet_id":"523454289876766720"}],"facebook":[{"title":"Applications of ImmunoPET: Using 124I-Anti-PSCA A11 Minibody for Imaging Disease Progression and...","url":"https:\/\/www.facebook.com\/202969119794991\/posts\/739332889491942","license":"public","citation_ids":[2790148],"posted_on":"2015-01-01T08:49:07+00:00","summary":"clincancerres.aacrjournals.org","author":{"name":"News su HIV, Cancro e Salute.","url":"https:\/\/www.facebook.com\/202969119794991","facebook_wall_name":"News su HIV, Cancro e Salute.","image":"https:\/\/graph.facebook.com\/202969119794991\/picture","id_on_source":"202969119794991"}}]}}